logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Transition From Crime To Care In Oncology A Critical Review Of Current Cancer Research And Its Applications Mohammad A Nezami

  • SKU: BELL-44800432
Transition From Crime To Care In Oncology A Critical Review Of Current Cancer Research And Its Applications Mohammad A Nezami
$ 31.00 $ 45.00 (-31%)

4.8

24 reviews

Transition From Crime To Care In Oncology A Critical Review Of Current Cancer Research And Its Applications Mohammad A Nezami instant download after payment.

Publisher: GMK Writing and Editing Inc.
File Extension: EPUB
File size: 5.68 MB
Pages: 208
Author: Mohammad A. Nezami, MD
ISBN: B0B6XFK4X8
Language: English
Year: 2022

Product desciption

Transition From Crime To Care In Oncology A Critical Review Of Current Cancer Research And Its Applications Mohammad A Nezami by Mohammad A. Nezami, Md B0B6XFK4X8 instant download after payment.

Cancer is widely regarded as the most challenging disease of our time. Conventional treatments and therapies generally address its symptoms, not the causes, which is why they largely prove ineffective. In his thought-provoking work, Transition from Crime to Care in Oncology, Dr. Mohammad A. Nezami-who has over a quarter of a century of experience conducting cutting-edge research treating this pernicious disease-shares his critical view on the current standard of care and colluded oncology research. He presents an eye-opening new understanding of cancer stem cell biology in concert with his "least toxic and most effective" approach to treatment. Dr. Nezami collaborates with major academic institutions and regulatory agencies while serving as a strong advocate of patients' rights of choice when it comes to treatment of terminal disease.
Insightful and revelatory, Dr. Nezami's groundbreaking work signals an enlightening and exciting new direction for the field of oncology.

Related Products